v3.26.1
Acquisition (Tables)
 3 Months Ended
Mar. 31, 2026
Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract]  
Schedule of Allocation of Purchase Price
The following summarizes the preliminary allocation of the BioConnect purchase price based on the fair value of the assets acquired and liabilities assumed, as of July 1, 2025:

July 1, 2025Measurement Period AdjustmentsJuly 1, 2025 (as adjusted)
Total Consideration:
   Cash paid$12,996,275 — 12,996,275 
   Less: cash acquired(113,545)— (113,545)
Total transaction consideration, net$12,882,730 $— $12,882,730 
Preliminary Allocation:
Assets acquired
   Accounts receivable$1,836,809 — 1,836,809 
   Inventory1,176,471 — 1,176,471 
   Prepaid expenses and other current assets111,143 — 111,143 
   Property, plant, and equipment63,866 — 63,866 
   Trade names and trademarks882,353 — 882,353 
   Developed technology6,617,647 (1,102,941)5,514,706 
   Customer relationships1,764,706 — 1,764,706 
   Goodwill3,399,491 429,743 3,829,234 
   Deferred tax asset— 673,198 673,198 
      Total assets acquired, excluding cash15,852,486 — 15,852,486 
Liabilities assumed:
   Accounts payable603,234 — 603,234 
   Accrued expenses and other current liabilities369,074 — 369,074 
   Other liabilities1,997,448 — 1,997,448 
      Total liabilities assumed2,969,756 — 2,969,756 
Net assets acquired, excluding cash$12,882,730 $— $12,882,730 
Schedule of Assets Acquired and Liabilities Assumed
The following summarizes the preliminary allocation of the BioConnect purchase price based on the fair value of the assets acquired and liabilities assumed, as of July 1, 2025:

July 1, 2025Measurement Period AdjustmentsJuly 1, 2025 (as adjusted)
Total Consideration:
   Cash paid$12,996,275 — 12,996,275 
   Less: cash acquired(113,545)— (113,545)
Total transaction consideration, net$12,882,730 $— $12,882,730 
Preliminary Allocation:
Assets acquired
   Accounts receivable$1,836,809 — 1,836,809 
   Inventory1,176,471 — 1,176,471 
   Prepaid expenses and other current assets111,143 — 111,143 
   Property, plant, and equipment63,866 — 63,866 
   Trade names and trademarks882,353 — 882,353 
   Developed technology6,617,647 (1,102,941)5,514,706 
   Customer relationships1,764,706 — 1,764,706 
   Goodwill3,399,491 429,743 3,829,234 
   Deferred tax asset— 673,198 673,198 
      Total assets acquired, excluding cash15,852,486 — 15,852,486 
Liabilities assumed:
   Accounts payable603,234 — 603,234 
   Accrued expenses and other current liabilities369,074 — 369,074 
   Other liabilities1,997,448 — 1,997,448 
      Total liabilities assumed2,969,756 — 2,969,756 
Net assets acquired, excluding cash$12,882,730 $— $12,882,730 
The following summarizes the allocation of the purchase price based on the fair value of the assets acquired and liabilities assumed, as of the Closing Date. The fair value of the Class A Common Stock acquired through this step acquisition is included in the totals presented below:

April 1, 2025Measurement Period AdjustmentsApril 1, 2025 (as adjusted)
Total Consideration:
   Cash paid$148,256,998 $— $148,256,998 
   Less: cash acquired(9,077,136)— (9,077,136)
Total cash paid, net139,179,862 — 139,179,862 
   Fair value of previously held investment in VOXX48,478,560 — 48,478,560 
Total transaction consideration, net$187,658,422 $— $187,658,422 
Allocation:
Assets acquired
   Accounts receivable$56,719,726 $— $56,719,726 
   Inventory96,718,000 — 96,718,000 
   Prepaid expenses and other current assets20,294,973 136,567 20,431,540 
   Income tax recoverable5,243,038 (962,335)4,280,703 
   Property, plant, and equipment44,977,000 — 44,977,000 
   Equity investment19,000,000 — 19,000,000 
   Deferred tax asset32,537,099 136,599 32,673,698 
   Goodwill— 16,478,978 16,478,978 
   Operating lease, right of use assets5,404,163 — 5,404,163 
   Other assets3,445,075 — 3,445,075 
      Total assets acquired, excluding cash284,339,074 15,789,809 300,128,883 
Liabilities assumed:
   Accounts payable31,347,556 (251,301)31,096,255 
   Accrued expenses and other current liabilities51,772,746 15,663,297 67,436,043 
   Income taxes payable684,033 377,813 1,061,846 
   Debt3,909,290 — 3,909,290 
   Other tax liabilities791,593 — 791,593 
   Operating lease liabilities3,435,604 — 3,435,604 
   Other liabilities1,260,830 — 1,260,830 
      Total liabilities assumed93,201,652 15,789,809 108,991,461 
Redeemable and non-redeemable non-controlling interests in consolidated subsidiaries3,479,000 — 3,479,000 
Net assets acquired, excluding cash$187,658,422 $— $187,658,422 
Schedule of Redeemable Noncontrolling Interest The following table provides the rollforward of the redeemable non-controlling interest for the three months ended March 31, 2026:
Redeemable Non-controlling Interest
Balance at January 1, 2026$3,102,213 
   Net loss attributable to non-controlling interest(34,084)
   Comprehensive income attributable to non-controlling interest424,415 
   Foreign currency translation(471,054)
Balance at March 31, 20263,021,490